title: Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.
abstract: Abnormal differentiation of myeloid cells is one of the hallmarks of cancer. However, the molecular mechanisms of this process remain elusive. In this study, we investigated the effect of tumor-derived factors on Janus kinase (Jak)/STAT signaling in myeloid cells during their differentiation into dendritic cells. Tumor cell conditioned medium induced activation of Jak2 and STAT3, which was associated with an accumulation of immature myeloid cells. Jak2/STAT3 activity was localized primarily in these myeloid cells, which prevented the differentiation of immature myeloid cells into mature dendritic cells. This differentiation was restored after removal of tumor-derived factors. Inhibition of STAT3 abrogated the negative effects of these factors on myeloid cell differentiation, and overexpression of STAT3 reproduced the effects of tumor-derived factors. Thus, this is a first demonstration that tumor-derived factors may affect myeloid cell differentiation in cancer via constitutive activation of Jak2/STAT3.
authors.affiliation: H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA.
authors.forename: Yulia
authors.initials: Y
authors.lastname: Nefedova
authors.forename: Mei
authors.initials: M
authors.lastname: Huang
authors.forename: Sergei
authors.initials: S
authors.lastname: Kusmartsev
authors.forename: Raka
authors.initials: R
authors.lastname: Bhattacharya
authors.forename: Pingyan
authors.initials: P
authors.lastname: Cheng
authors.forename: Raoul
authors.initials: R
authors.lastname: Salup
authors.forename: Richard
authors.initials: R
authors.lastname: Jove
authors.forename: Dmitry
authors.initials: D
authors.lastname: Gabrilovich
mesh_terms: D000818:Animals; D002449:Cell Aggregation / Q000276:immunology; D002454:Cell Differentiation / Q000276:immunology; D002455:Cell Division / Q000276:immunology; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D004268:DNA-Binding Proteins / Q000378:metabolism* / Q000502:physiology; D003713:Dendritic Cells / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology*; D005260:Female; D006131:Growth Inhibitors / Q000502:physiology; D006412:Hematopoietic Stem Cells / Q000276:immunology / Q000473:pathology; D053614:Janus Kinase 2; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D022423:Myeloid Cells / Q000378:metabolism / Q000473:pathology; D041681:NIH 3T3 Cells; D009363:Neoplasm Proteins / Q000502:physiology; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D011518:Proto-Oncogene Proteins; D050796:STAT3 Transcription Factor; D015398:Signal Transduction / Q000276:immunology*; D015534:Trans-Activators / Q000378:metabolism* / Q000502:physiology; D015854:Up-Regulation / Q000276:immunology
chemical_list: D004268:DNA-Binding Proteins; D006131:Growth Inhibitors; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D050796:STAT3 Transcription Factor; C494087:Stat3 protein, mouse; D015534:Trans-Activators; D011505:Protein-Tyrosine Kinases; C507926:Jak2 protein, mouse; D053614:Janus Kinase 2